Dogwood Therapeutics, Inc.

NASDAQ (USD): Dogwood Therapeutics, Inc. (DWTX)

Last Price

10.74

Today's Change

-1.07 (9.06%)

Day's Change

10.51 - 12.05

Trading Volume

102,346

Overview

Market Cap

14 Million

Shares Outstanding

1 Million

Avg Volume

2,650,948

Avg Price (50 Days)

4.87

Avg Price (200 Days)

5.43

PE Ratio

-1.73

EPS

-6.32

Earnings Announcement

26-Feb-2025

Previous Close

11.81

Open

11.80

Day's Range

10.5 - 12.0499

Year Range

1.62 - 29.28

Trading Volume

102,346

Price Change Highlight

1 Day Change

-7.37%

5 Day Change

-12.48%

1 Month Change

363.56%

3 Month Change

154.42%

6 Month Change

149.77%

Ytd Change

335.86%

1 Year Change

4.39%

3 Year Change

-93.08%

5 Year Change

-97.38%

10 Year Change

-97.38%

Max Change

-97.38%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Dogwood Therapeutics, Inc., a development-stage biotechnology company, focuses on developing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It also develops IMC-2, a combination of valacyclovir and celecoxib for the treatment of managing the fatigue, sleep, attention, pain, autonomic function, and anxiety associated with long COVID. The company was formerly known as Virios Therapeutics, Inc. and changed its name to Dogwood Therapeutics, Inc. in October 2024. The company was founded in 2012 and is headquartered in Alpharetta, Georgia.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment